CRISPR-Cas Systems: New Players in Bacterial Gene Regulation, Innate Immune Evasion, Pathogenesis, and Beyond Open Access
Sampson, Timothy Robert (2014)
Abstract
CRISPR (clustered, regularly interspaced, short palindromic repeats) - Cas (CRISPR-associated) systems are a form of prokaryotic defense against invading foreign nucleic acids, particularly those derived from bacteriophages and plasmids. Such foreign nucleic acids are targeted and cleaved by CRISPR-Cas systems in an RNA-dependent, sequence-specific manner. Additionally, CRISPR-Cas systems are adaptive, providing protection against previously encountered foreign elements. Canonically, it has been thought that these restriction systems act solely in prokaryotic immunity against exogenous genetic elements. However, here, we reveal the very first demonstration of a unique role for CRISPR-Cas systems in the control of endogenous gene expression, a previously unappreciated form of prokaryotic gene regulation. We demonstrate that in the intracellular bacterial pathogen, Francisella novicida, the CRISPR-Cas endonuclease, Cas9, functions in association with two small RNAs to target and alter the stability of a particular endogenous transcript which encodes a bacterial lipoprotein (BLP). Since BLPs are recognized by the host innate immune receptor Toll-like Receptor 2 (TLR2), CRISPR-Cas-mediated repression of BLP expression dampens the activation of TLR2-dependent immune signaling. Furthermore, we demonstrate that control of BLP levels in F. novicida promotes resistance to antimicrobials and enhances the stability of the bacterial envelope, which additionally allows evasion of the host inflammasome complex. Dampening the activation of both TLR2 and the inflammasome by Cas9-mediate regulation ultimately promotes the successful survival of this pathogen in the mammalian host. Since ~45% of bacteria and ~83% of Archaea encode these machineries, this newly described regulatory function of CRISPR-Cas systems is likely to play a broad role in controlling the pathogenesis and physiology of diverse prokaryotes.
Table of Contents
Chapter 1 Introduction...................................................................................... 1 Thesis Overview............................................................................. 14 References...................................................................................... 15
Chapter 2 Repression of bacterial lipoprotein production by Francisella novicida facilitates evasion of innate immune recognition
Abstract.............................................................................. 24
Introduction........................................................................ 25
Results................................................................................ 26
Discussion.......................................................................... 38
Materials & Methods.......................................................... 41
References.......................................................................... 47
Figures................................................................................ 52
Supplemental Information.................................................. 58
Chapter 3 A CRISPR-Cas system mediates bacterial innate immune evasion and virulence
Abstract.............................................................................. 64
Introduction........................................................................ 65
Results................................................................................ 66
Discussion.......................................................................... 71
Materials & Methods.......................................................... 72
References.......................................................................... 77
Figures................................................................................ 80
Chapter 4 A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion
Abstract.............................................................................. 86
Introduction........................................................................ 87
Results................................................................................ 90
Discussion.......................................................................... 97
Materials & Methods........................................................ 102
References........................................................................ 106
Figures.............................................................................. 109
Supplemental Information................................................ 113
Chapter 5 Degeneration of a CRISPR-Cas system and its regulatory target during the evolution of a pathogen
Abstract............................................................................ 124
Introduction...................................................................... 125
Results & Discussion........................................................ 128
References........................................................................ 136
Figures.............................................................................. 139
Chapter 6 Discussion of CRISPR-Cas - mediated gene regulation
Summary & Predicted Mechanism of RNA Targeting ...... 141
Role of CRISPR-Cas gene regulation in pathogenesis....... 145
Role of CRISPR-Cas in the response to envelope stress
......................................................................................... 147
Role of other CRISPR-Cas systems in bacterial physiology
......................................................................................... 148
Conclusions...................................................................... 152
References........................................................................ 153
Figures.............................................................................. 157
Chapter 7 Cas9 as a platform for genome engineering and implications for Cas9-mediated RNA targeting
Cas9 in genome engineering............................................. 159
Engineering to control transcription.................................. 161
Engineering Francisella Cas9 to target viral RNA in eukaryotic cells 162
Thesis Conclusions........................................................... 165References........................................................................ 166
Figures.............................................................................. 169
About this Dissertation
School | |
---|---|
Department | |
Subfield / Discipline | |
Degree | |
Submission | |
Language |
|
Research Field | |
Keyword | |
Committee Chair / Thesis Advisor | |
Committee Members |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
|
CRISPR-Cas Systems: New Players in Bacterial Gene Regulation, Innate Immune Evasion, Pathogenesis, and Beyond () | 2018-08-28 11:50:07 -0400 |
|
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|